Azido-Lactone Protein Modification for Site-Selective Acylation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for site-selective modification of proteins, particularly at the N-terminus, face challenges such as off-site modifications and heterogeneity in biopharmaceutical formulations, antibody-drug conjugates, and biomaterials, due to limitations in existing chemical and enzymatic approaches.

Innovation Solution

The synthesis of azido-substituted lactone derivatives allows for site-specific modification of proteins through a more atom-economical and chemically safer route, enabling efficient acylation of proteins and subsequent purification, while minimizing off-site modifications and heterogeneity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional chemical groups (amino, carboxyl, sulfhydryl) are targeted for protein conjugation, then abundant reaction sites are available, but heterogeneous subpopulations of bioconjugates are obtained

Engineering Contradiction:
Improvereaction efficiencyVSAvoidsite-selectivity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent introduces a unique N-terminal tag sequence (e.g., MGSSHHHHHH) that creates a localized reactive site with distinct chemical properties. The N-terminal amino group has a lower pKa (7.6-8.0) compared to Lys side-chain ε-amines (pKa 10.5+1.1), enabling pH-controlled selective acylation or alkylation at this specific location while leaving other abundant amino groups untouched throughout the protein structure

Inventive Principle:
Principle #3Local quality

2Manufacturing precision

If N-terminal modification is performed at pH 7.6-8.0, then selective acylation or alkylation is achieved, but off-site modifications may still occur

Engineering Contradiction:
Improvesite-selectivityVSAvoidmodification specificity
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent incorporates a predetermined N-terminal tag sequence (such as MGSSHHHHHH) into the protein expression system before the modification reaction. This pre-engineered tag creates a unique chemical environment at the N-terminus with lowered pKa, preparing the site for selective pH-controlled modification and preventing off-site reactions by making other amino groups non-competitive at the chosen pH range

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent exploits the pH-dependent protonation state of amino groups to achieve selectivity. By performing modification at pH 7.6-8.0, the N-terminal amino group (pKa 7.6-8.0) is partially deprotonated and reactive, while Lys side-chain ε-amines (pKa 10.5+1.1) remain predominantly protonated and unreactive, thus changing the chemical parameter (pH) to control site-specificity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables precise and efficient site-selective modification of proteins, reducing heterogeneity and improving the stability and bioavailability of protein derivatives, thereby enhancing the reliability of biopharmaceutical formulations and biomaterials.

Implementation Method 1

contacting a handle-substituted aldose with a catalyst under aprotic conditions in the presence of a hydrogen acceptor

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20230212216A1Synthesis of lactone derivatives and their use in the modification of proteins
Publication Date: 2023.07.06 GENIE BIOTECH UK LTD
  • US20230212216A1 patent drawing
  • US20230212216A1 patent drawing
  • US20230212216A1 patent drawing

AI summary

Site-specific modifications of proteins are desirable in biotechnological applications such as biopharmaceuticals, immunotherapy, vaccines, and are useful in chemical biology. Gluconoylation is a non-enzymatic, covalent, post-translational modification commonly observed on N-terminal His-Tags bearing proteins. We synthesized glucono-1,5-lactone derivatives, including azido variants for selective acylation. High yield acylation is achieved by simply mixing derivatives with target protein amidst diverse conditions of temperatures, aqueous buffers, excipients, or complex cell lysate.